Title |
Spotlight on Givosiran as a Treatment Option for Adults with Acute Hepatic Porphyria: Design, Development, and Place in Therapy
|
---|---|
Published in |
Drug Design, Development and Therapy, June 2022
|
DOI | 10.2147/dddt.s281631 |
Pubmed ID | |
Authors |
Chaudry Nasir Majeed, Christopher D, Ted Xiao, Sean Rudnick, Herbert L Bonkovsky |
Mendeley readers
The data shown below were compiled from readership statistics for 31 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 31 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Bachelor | 6 | 19% |
Student > Ph. D. Student | 3 | 10% |
Student > Master | 2 | 6% |
Researcher | 2 | 6% |
Professor | 1 | 3% |
Other | 3 | 10% |
Unknown | 14 | 45% |
Readers by discipline | Count | As % |
---|---|---|
Pharmacology, Toxicology and Pharmaceutical Science | 4 | 13% |
Medicine and Dentistry | 3 | 10% |
Chemistry | 2 | 6% |
Biochemistry, Genetics and Molecular Biology | 1 | 3% |
Business, Management and Accounting | 1 | 3% |
Other | 4 | 13% |
Unknown | 16 | 52% |